Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation

被引:309
作者
Dorn, GW
Souroujon, MC
Liron, T
Chen, CH
Gray, MO
Zhou, HZ
Csukai, M
Wu, GY
Lorenz, JN
Mochly-Rosen, D [1 ]
机构
[1] Univ Cincinnati, Dept Med, Cincinnati, OH 45167 USA
[2] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA
[3] Open Univ, Dept Nat & Life Sci, IL-61392 Tel Aviv, Israel
[4] Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA
[6] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94121 USA
关键词
preconditioning; hypoxia; transgenic pseudoreceptors for activated C-kinase; ischemia;
D O I
10.1073/pnas.96.22.12798
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Brief periods of cardiac ischemia trigger protection from subsequent prolonged ischemia (preconditioning). epsilon Protein kinase C (epsilon PKC) has been suggested to mediate preconditioning. Here, we describe an epsilon PKC-selective agonist octapeptide, psi epsilon receptor for activated C-kinase (psi epsilon RACK). derived from an epsilon PKC sequence homologous to its anchoring protein, epsilon RACK, Introduction of psi epsilon RACK into isolated cardiomyocytes, or its postnatal expression as a transgene in mouse hearts, increased epsilon PKC translocation and caused cardio-protection from ischemia without any deleterious effects. Our data demonstrate that epsilon PKC activation is required for protection from ischemic insult and suggest that small molecules that mimic this epsilon PKC agonist octapeptide provide a powerful therapeutic approach to protect hearts at risk for ischemia.
引用
收藏
页码:12798 / 12803
页数:6
相关论文
共 36 条
[1]   MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure [J].
Arber, S ;
Hunter, JJ ;
Ross, J ;
Hongo, M ;
Sansig, G ;
Borg, J ;
Perriard, JC ;
Chien, KR ;
Caroni, P .
CELL, 1997, 88 (03) :393-403
[2]   PRECONDITIONING OF ISOLATED RABBIT CARDIOMYOCYTES - INDUCTION BY METABOLIC STRESS AND BLOCKADE BY THE ADENOSINE ANTAGONIST SPT AND CALPHOSTIN-C, A PROTEIN-KINASE-C INHIBITOR [J].
ARMSTRONG, S ;
DOWNEY, JM ;
GANOTE, CE .
CARDIOVASCULAR RESEARCH, 1994, 28 (01) :72-77
[3]   Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice [J].
Colbert, MC ;
Hall, DG ;
Kimball, TR ;
Witt, SA ;
Lorenz, JN ;
Kirby, ML ;
Hewett, TE ;
Klevitsky, R ;
Robbins, J .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :1958-1968
[4]   The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase C epsilon [J].
Csukai, M ;
Chen, CH ;
DeMatteis, MA ;
MochlyRosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29200-29206
[5]  
DEROSSI D, 1994, J BIOL CHEM, V269, P10444
[6]   LOCALIZATION OF PROTEIN-KINASE-C ISOZYMES IN CARDIAC MYOCYTES [J].
DISATNIK, MH ;
BURAGGI, G ;
MOCHLYROSEN, D .
EXPERIMENTAL CELL RESEARCH, 1994, 210 (02) :287-297
[7]   A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death [J].
Gray, MO ;
Karliner, JS ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30945-30951
[8]   Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress [J].
Hirota, H ;
Chen, J ;
Betz, UAK ;
Rajewsky, K ;
Gu, Y ;
Ross, J ;
Müller, W ;
Chien, KR .
CELL, 1999, 97 (02) :189-198
[9]   A SYNTHETIC PEPTIDE ANALOG OF THE PUTATIVE SUBSTRATE-BINDING MOTIF ACTIVATES PROTEIN KINASE-C [J].
HOUSE, C ;
ROBINSON, PJ ;
KEMP, BE .
FEBS LETTERS, 1989, 249 (02) :243-247
[10]   An improved permeabilization protocol for the introduction of peptides into cardiac myocytes - Application to protein kinase C research [J].
Johnson, JA ;
Gray, MO ;
Karliner, JS ;
Chen, CH ;
MochlyRosen, D .
CIRCULATION RESEARCH, 1996, 79 (06) :1086-1099